Speech in Lords Chamber - Tue 05 Apr 2022
Health and Care Bill
"My Lords, I want to contribute to this group and speak to Motions G1, G2 and H. As context, I say that my noble friend, the Front Bench team and their Bill team have gone to enormous efforts to try to reach a number of compromises; at this stage it …..."Lord Lansley - View Speech
View all Lord Lansley (Con - Life peer) contributions to the debate on: Health and Care Bill
Speech in Grand Committee - Mon 14 Mar 2022
Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2022
"My Lords, I am glad to have the opportunity of contributing to this debate. If I may, I shall say something about each of the two regulations we are looking at. Before I go down that path, I should declare an interest as vice-chair of the All-Party Parliamentary Group on …..."Lord Lansley - View Speech
View all Lord Lansley (Con - Life peer) contributions to the debate on: Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2022
Written Question
Wednesday 9th March 2022
Asked by:
Lord Lansley (Conservative - Life peer)
Question
to the Department of Health and Social Care:
To ask Her Majesty's Government what plans they have to provide pre-exposure prophylaxis against COVID-19 to the most vulnerable groups who are severely immunocompromised.
Answered by Lord Kamall
- Shadow Minister (Health and Social Care)
The Department is exploring prophylactic use of antivirals for the immunocompromised and evidence continues to be reviewed for potential use in the National Health Service.
The RAPID C-19 collaboration considers national and international trial evidence as it emerges for COVID-19 therapies, for potential treatment and prophylactic indications.
Later this spring, a post-exposure prophylaxis sub-study is expected as part of the PANORAMIC national study to investigate the effect of prescribing oral antivirals to those who are a household contact of a COVID-19 positive individual. In addition, the PROTECT-V study is trialling sotrovimab and niclosamide as prophylactic drugs administered over a six-month period in vulnerable renal and immunosuppressed patients.
Written Question
Tuesday 8th March 2022
Asked by:
Lord Lansley (Conservative - Life peer)
Question
to the Department of Health and Social Care:
To ask Her Majesty's Government what assessment they have made of the emergency use authorisation listed on 8 December 2021 of AstraZeneca's Evusheld for pre-exposure prophylaxis in (1) certain adults, and (2) children.
Answered by Lord Kamall
- Shadow Minister (Health and Social Care)
We are aware that the United States Food and Drug Administration (FDA) listed an emergency use authorisation for Evusheld in December 2021, which was revised on 24 February 2022. The FDA has modified their dosing regimen according to its available data and consider that a higher dose of Evusheld may be more likely to prevent infection by the Omicron subvariants BA.1 and BA.1.1 than the originally authorised Evusheld dose.
We continue to monitor emerging data for Evusheld and other treatments for applicability in the United Kingdom for prevalent variants and which patient groups could potentially benefit. Evusheld is not currently authorised in the UK.
Speech in Lords Chamber - Thu 03 Mar 2022
Health and Care Bill
"..."Lord Lansley - View Speech
View all Lord Lansley (Con - Life peer) contributions to the debate on: Health and Care Bill
Speech in Lords Chamber - Thu 03 Mar 2022
Health and Care Bill
"My Lords, Amendments 61, 95 and 96, which are all in my name, are to two separate issues. Amendment 61 relates to an issue we debated a number of times in Committee, when, if I may presume, there was a degree of support among noble Lords for the proposition that …..."Lord Lansley - View Speech
View all Lord Lansley (Con - Life peer) contributions to the debate on: Health and Care Bill
Speech in Lords Chamber - Thu 03 Mar 2022
Health and Care Bill
"My Lords, I am most grateful to noble Lords for their support, and to my noble friend for responding. I have a couple of important things to say.
First, I was not suggesting these things. I was suggesting that the legislation should reflect what the Government’s intentions are, because the …..."Lord Lansley - View Speech
View all Lord Lansley (Con - Life peer) contributions to the debate on: Health and Care Bill
Speech in Lords Chamber - Thu 03 Mar 2022
Health and Care Bill
"..."Lord Lansley - View Speech
View all Lord Lansley (Con - Life peer) contributions to the debate on: Health and Care Bill
Speech in Lords Chamber - Thu 03 Mar 2022
Health and Care Bill
"My Lords, this group of amendments in my name relates to Clause 26. Noble Lords will recall that we had a rather helpful debate about this in Committee. The point is that the Care Quality Commission is an independent organisation. We want to respect that and see that carried through …..."Lord Lansley - View Speech
View all Lord Lansley (Con - Life peer) contributions to the debate on: Health and Care Bill
Speech in Lords Chamber - Thu 03 Mar 2022
Health and Care Bill
"I am most grateful to my noble friend and for the support of noble Lords for the concept. I hope the CQC will find that this assists it in ensuring that it remains independent in how it goes about its job, and, indeed, how it derives indicators of quality and …..."Lord Lansley - View Speech
View all Lord Lansley (Con - Life peer) contributions to the debate on: Health and Care Bill